Skip to main content


Fig. 5 | BMC Neurology

Fig. 5

From: Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study

Fig. 5

Proportion relapsed at each year by T1 Gd + lesions at 6 months. a Placebo/delayed treatment group; b IFN β-1a 22 μg SC tiw group; c IFN β-1a 44 μg SC tiw group. No statistically significant differences were seen in any of the treatment groups. Values were based on logistic regression model adjusting for number of relapses within the previous 2 years, age, baseline EDSS score, and baseline T1 Gd + lesions. p values were calculated for the predictive effect of T1 Gd + lesions. EDSS: Expanded Disability Status Scale; Gd+: gadolinium-enhancing; IFN β-1a: interferon beta-1a; SC: subcutaneously; tiw: three times weekly

Back to article page